Trial Profile
Pharmacodynamics of mepolizumab in patients with mild allergic asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Allergic asthma
- Focus Biomarker; Pharmacodynamics
- 05 Nov 2010 New trial record.